Literature DB >> 10637316

A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.

L A Pereira1, K Bentley, A Peeters, M J Churchill, N J Deacon.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) represents a model promoter system and the identification and characterisation of cellular proteins that interact with this region has provided a basic understanding about both general eukaryotic and HIV-1 proviral transcriptional regulation. To date a large number of sequence-specific DNA-protein interactions have been described for the HIV-1 LTR. The aim of this report is to provide a comprehensive, updated listing of these HIV-1 LTR interactions. It is intended as a reference point to facilitate on-going studies characterising the identity of cellular proteins interacting with the HIV-1 LTR and the functional role(s) of specific regions of the LTR for HIV-1 replication.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10637316      PMCID： PMC102541          DOI： 10.1093/nar/28.3.663

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


  85 in total

1.  Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity.

Authors:  C Van Lint; C A Amella; S Emiliani; M John; T Jie; E Verdin
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Hematopoietic transcription factor GATA-2 activates transcription from HIV-1 long terminal repeat.

Authors:  M Towatari; Y Kanei; H Saito; M Hamaguchi
Journal:  AIDS       Date:  1998-02-12       Impact factor: 4.177

3.  U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins.

Authors:  M F Rabbi; M Saifuddin; D S Gu; M F Kagnoff; K A Roebuck
Journal:  Virology       Date:  1997-06-23       Impact factor: 3.616

4.  Involvement of protein-DNA interaction in adeno-associated virus Rep78-mediated inhibition of HIV-1.

Authors:  N A Kokorina; A D Santin; C Li; P L Hermonat
Journal:  J Hum Virol       Date:  1998 Nov-Dec

5.  Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.

Authors:  B E Sawaya; K Khalili; S Amini
Journal:  J Gen Virol       Date:  1998-02       Impact factor: 3.891

6.  Isolation and initial characterization of GBF, a novel DNA-binding zinc finger protein that binds to the GC-rich binding sites of the HIV-1 promoter.

Authors:  T Suzuki; T Yamamoto; M Kurabayashi; R Nagai; Y Yazaki; M Horikoshi
Journal:  J Biochem       Date:  1998-08       Impact factor: 3.387

7.  Interaction between cell cycle regulator, E2F-1, and NF-kappaB mediates repression of HIV-1 gene transcription.

Authors:  M Kundu; M Guermah; R G Roeder; S Amini; K Khalili
Journal:  J Biol Chem       Date:  1997-11-21       Impact factor: 5.157

8.  Involvement of Ets, rel and Sp1-like proteins in lipopolysaccharide-mediated activation of the HIV-1 LTR in macrophages.

Authors:  M J Sweet; K J Stacey; I L Ross; M C Ostrowski; D A Hume
Journal:  J Inflamm       Date:  1998

9.  Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription.

Authors:  M C Estable; B Bell; M Hirst; I Sadowski
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication.

Authors:  Y Honda; L Rogers; K Nakata; B Y Zhao; R Pine; Y Nakai; K Kurosu; W N Rom; M Weiden
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307
View more
  140 in total

1.  HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.

Authors:  B Bramlage; E Luzi; F Eckstein
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

2.  Chromatin disruption and histone acetylation in regulation of the human immunodeficiency virus type 1 long terminal repeat by thyroid hormone receptor.

Authors:  Shao-Chung Victor Hsia; Yun-Bo Shi
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

3.  Functional nuclear topography of transcriptionally inducible extra-chromosomal transgene clusters.

Authors:  Manja Meggendorfer; Claudia Weierich; Horst Wolff; Ruth Brack-Werner; Thomas Cremer
Journal:  Chromosome Res       Date:  2010-06-08       Impact factor: 5.239

4.  Identification of T cell-signaling pathways that stimulate latent HIV in primary cells.

Authors:  David G Brooks; Philip A Arlen; Lianying Gao; Christina M R Kitchen; Jerome A Zack
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

5.  HIV develops indirect cross-resistance to combinatorial RNAi targeting two distinct and spatially distant sites.

Authors:  Priya S Shah; Nhung P Pham; David V Schaffer
Journal:  Mol Ther       Date:  2012-01-31       Impact factor: 11.454

6.  Negative elongation factor (NELF) coordinates RNA polymerase II pausing, premature termination, and chromatin remodeling to regulate HIV transcription.

Authors:  Malini Natarajan; Gillian M Schiralli Lester; Chanhyo Lee; Anamika Missra; Gregory A Wasserman; Martin Steffen; David S Gilmour; Andrew J Henderson
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

7.  Direct interaction of the human I-mfa domain-containing protein, HIC, with HIV-1 Tat results in cytoplasmic sequestration and control of Tat activity.

Authors:  Virginie W Gautier; Noreen Sheehy; Margaret Duffy; Kenichi Hashimoto; William W Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

8.  Genetic analysis of the long terminal repeat (LTR) promoter region in HIV-1-infected individuals with different rates of disease progression.

Authors:  Eva Ramírez de Arellano; Cristina Martín; Vincent Soriano; José Alcamí; Africa Holguín
Journal:  Virus Genes       Date:  2006-12-09       Impact factor: 2.332

9.  Are viral-encoded microRNAs mediating latent HIV-1 infection?

Authors:  Marc S Weinberg; Kevin V Morris
Journal:  DNA Cell Biol       Date:  2006-04       Impact factor: 3.311

10.  Functional Incompatibility between the Generic NF-κB Motif and a Subtype-Specific Sp1III Element Drives the Formation of the HIV-1 Subtype C Viral Promoter.

Authors:  Anjali Verma; Pavithra Rajagopalan; Rishikesh Lotke; Rebu Varghese; Deepak Selvam; Tapas K Kundu; Udaykumar Ranga
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.